1
|
Botter E, Caligiuri I, Rizzolio F, Visentin F, Scattolin T. Liposomal Formulations of Metallodrugs for Cancer Therapy. Int J Mol Sci 2024; 25:9337. [PMID: 39273286 PMCID: PMC11394711 DOI: 10.3390/ijms25179337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2024] [Revised: 08/22/2024] [Accepted: 08/26/2024] [Indexed: 09/15/2024] Open
Abstract
The search for new antineoplastic agents is imperative, as cancer remains one of the most preeminent causes of death worldwide. Since the discovery of the therapeutic potential of cisplatin, the study of metallodrugs in cancer chemotherapy acquired increasing interest. Starting from cisplatin derivatives, such as oxaliplatin and carboplatin, in the last years, different compounds were explored, employing different metal centers such as iron, ruthenium, gold, and palladium. Nonetheless, metallodrugs face several drawbacks, such as low water solubility, rapid clearance, and possible side toxicity. Encapsulation has emerged as a promising strategy to overcome these issues, providing both improved biocompatibility and protection of the payload from possible degradation in the biological environment. In this respect, liposomes, which are spherical vesicles characterized by an aqueous core surrounded by lipid bilayers, have proven to be ideal candidates due to their versatility. In fact, they can encapsulate both hydrophilic and hydrophobic drugs, are biocompatible, and their properties can be tuned to improve the selective delivery to tumour sites exploiting both passive and active targeting. In this review, we report the most recent findings on liposomal formulations of metallodrugs, with a focus on encapsulation techniques and the obtained biological results.
Collapse
Affiliation(s)
- Eleonora Botter
- Department of Molecular Sciences and Nanosystems, Università Ca' Foscari Campus Scientifico, Via Torino 155, 30174 Venezia-Mestre, Italy
| | - Isabella Caligiuri
- Pathology Unit, Department of Molecular Biology and Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Via Franco Gallini 2, 33081 Aviano, Italy
| | - Flavio Rizzolio
- Department of Molecular Sciences and Nanosystems, Università Ca' Foscari Campus Scientifico, Via Torino 155, 30174 Venezia-Mestre, Italy
- Pathology Unit, Department of Molecular Biology and Translational Research, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Via Franco Gallini 2, 33081 Aviano, Italy
| | - Fabiano Visentin
- Department of Molecular Sciences and Nanosystems, Università Ca' Foscari Campus Scientifico, Via Torino 155, 30174 Venezia-Mestre, Italy
| | - Thomas Scattolin
- Dipartimento di Scienze Chimiche, Università degli Studi di Padova, Via Marzolo 1, 35131 Padova, Italy
| |
Collapse
|
2
|
Kazimir A, Schwarze B, Lönnecke P, Jelača S, Mijatović S, Maksimović-Ivanić D, Hey-Hawkins E. Metallodrugs against Breast Cancer: Combining the Tamoxifen Vector with Platinum(II) and Palladium(II) Complexes. Pharmaceutics 2023; 15:pharmaceutics15020682. [PMID: 36840003 PMCID: PMC9959148 DOI: 10.3390/pharmaceutics15020682] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2023] [Revised: 01/30/2023] [Accepted: 02/09/2023] [Indexed: 02/19/2023] Open
Abstract
The luminal A-subtype of breast cancer, where the oestrogen receptor α (ERα) is overexpressed, is the most frequent one. The prodrug tamoxifen (1) is the clinically used agent, inhibiting the ERα activity via the formation of several active metabolites, such as 4-hydroxytamoxifen (2) or 4,4'-dihydroxytamoxifen (3). In this study, we present the tamoxifen derivative 4-[1,1-bis(4-methoxyphenyl)but-1-en-2-yl]-2,2'-bipyridine (4), which was combined with platinum or palladium dichloride, the former a well-known scaffold in anticancer treatment, to give [PtCl2(4-κ2N,N')] (5) or [PdCl2(4-κ2N,N'] (6). To prevent fast exchange of weakly coordinating chlorido ligands in aqueous solution, a bulky, highly stable and hydrophobic nido-carborate(-2) ([C2B9H11]2-) was incorporated. The resulting complexes [3-(4-κ2N,N')-3,1,2-PtC2B9H11] (7) and [3-(4-κ2N,N')-3,1,2-PdC2B9H11] (8) exhibit a dramatic change in electronic and biological properties compared to 5 and 6. Thus, 8 is highly selective for triple-negative MDA-MB-231 cells (IC50 = 3.7 μM, MTT test), while 7 is completely inactive against this cell line. The observed cytotoxicity of compounds 4-6 and 8 against this triple-negative cell line suggests off-target mechanisms rather than only ERα inhibition, for which these compounds were originally designed. Spectroscopic properties and electronic structures of the metal complexes were investigated for possible explanations of the biological activities.
Collapse
Affiliation(s)
- Aleksandr Kazimir
- Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany
| | - Benedikt Schwarze
- Institute for Medical Physics and Biophysics, Medical Faculty, Leipzig University, 04107 Leipzig, Germany
| | - Peter Lönnecke
- Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany
| | - Sanja Jelača
- Department of Immunology, Institute for Biological Research “Siniša Stanković”, National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia
| | - Sanja Mijatović
- Department of Immunology, Institute for Biological Research “Siniša Stanković”, National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia
| | - Danijela Maksimović-Ivanić
- Department of Immunology, Institute for Biological Research “Siniša Stanković”, National Institute of Republic of Serbia, University of Belgrade, 11060 Belgrade, Serbia
| | - Evamarie Hey-Hawkins
- Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Leipzig University, 04103 Leipzig, Germany
- Correspondence:
| |
Collapse
|
3
|
Idlas P, Ladaycia A, Némati F, Lepeltier E, Pigeon P, Jaouen G, Decaudin D, Passirani C. Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma. Int J Pharm 2022; 626:122164. [PMID: 36089209 DOI: 10.1016/j.ijpharm.2022.122164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 07/22/2022] [Accepted: 08/29/2022] [Indexed: 10/14/2022]
Abstract
Ovarian cancer is one of the deadliest epithelial malignancies in women, owing to the multidrug resistance that restricts the success of conventional chemotherapy, carboplatin and paclitaxel. High grade serous ovarian carcinoma can be classified into two subtypes, the chemosensitive High OXPHOS and the Low OXPHOS tumour, less sensitive to chemotherapy. This difference of treatment efficacy could be explained by the redox status of these tumours, High OXPHOS exhibiting a chronic oxidative stress and an accumulation of reactive oxygen species. Ferrocifens, bio-organometallic compounds, are believed to be ROS producers with a good cytotoxicity on ovarian cancer cell lines. The aim of this study was to evaluate the in vivo efficacy of ferrocifen stealth lipid nanocapsules on High and Low OXPHOS ovarian Patient-Derived Xenograft models, alone or in combination to standard chemotherapy. Accordingly, two ferrocifens, P53 and P722, were encapsulated in stealth LNCs. The treatment by stealth P722-LNCs in combination with standard chemotherapy induced, with a concentration eight time lower than in stealth P53-LNCs, similar tumour reduction on a Low OXPHOS model, allowing us to conclude that P722 could be a leading ferrocifen to treat ovarian cancer. This combination of treatments may represent a promising synergistic approach to treat resistant ovarian adenocarcinoma.
Collapse
Affiliation(s)
- Pierre Idlas
- Micro et Nanomédecines Translationnelles, MINT, UNIV Angers, INSERM 1066, CNRS 6021, Angers, France
| | - Abdallah Ladaycia
- Micro et Nanomédecines Translationnelles, MINT, UNIV Angers, INSERM 1066, CNRS 6021, Angers, France
| | - Fariba Némati
- Translational Research Department, Laboratory of preclinical Investigation, PSL University, Institut Curie, 26 rue d'Ulm, Paris 75248, France
| | - Elise Lepeltier
- Micro et Nanomédecines Translationnelles, MINT, UNIV Angers, INSERM 1066, CNRS 6021, Angers, France
| | - Pascal Pigeon
- PSL Chimie Paris Tech, 11 rue P. et M. Curie and Sorbonne Université IPCM, CNRS, UMR 8232, IPCM, Paris 75005, France
| | - Gerard Jaouen
- PSL Chimie Paris Tech, 11 rue P. et M. Curie and Sorbonne Université IPCM, CNRS, UMR 8232, IPCM, Paris 75005, France
| | - Didier Decaudin
- Translational Research Department, Laboratory of preclinical Investigation, PSL University, Institut Curie, 26 rue d'Ulm, Paris 75248, France; Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, Paris 75248, France
| | - Catherine Passirani
- Micro et Nanomédecines Translationnelles, MINT, UNIV Angers, INSERM 1066, CNRS 6021, Angers, France
| |
Collapse
|
4
|
Schröder M, Petrova M, Vlahova Z, Dobrikov GM, Slavchev I, Pasheva E, Ugrinova I. In Vitro Anticancer Activity of Two Ferrocene-Containing Camphor Sulfonamides as Promising Agents against Lung Cancer Cells. Biomedicines 2022; 10:biomedicines10061353. [PMID: 35740374 PMCID: PMC9219647 DOI: 10.3390/biomedicines10061353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 05/31/2022] [Accepted: 06/06/2022] [Indexed: 11/16/2022] Open
Abstract
The successful design of antitumour drugs often combines in one molecule different biologically active subunits that can affect various regulatory pathways in the cell and thus achieve higher efficacy. Two ferrocene derivatives, DK-164 and CC-78, with different residues were tested for cytotoxic potential on non-small lung cancer cell lines, A549 and H1299, and non-cancerous MRC5. DK-164 demonstrated remarkable selectivity toward cancer cells and more pronounced cytotoxicity against A549. The cytotoxicity of CC-78 toward H1299 was even higher than that of the well-established anticancer drugs cisplatin and tamoxifen, but it did not reveal any noticeable selective effect. DK-164 showed predominantly pro-apoptotic activity in non-small cell lung carcinoma (NSCLC) cells, while CC-78 caused accidental cell death with features characteristic of necrosis. The level of induced autophagy was similar for both substances in cancer cells. DK-164 treatment of A549, H1299, and MRC5 cells for 48 h significantly increased the fluorescence signal of the NFkB (nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells) protein in the nucleus in all three cell lines, while CC-78 did not provoke NFkB translocation in any of the tested cell lines. Both compounds caused a significant transfer of the p53 protein in the nucleus of A549 cells but not in non-cancerous MRC5 cells. In A549, DK-164 generated oxidative stress close to the positive control after 48 h, while CC-78 had a moderate effect on the cellular redox status. In the non-cancerous cells, MRC5, both compounds produced ROS similar to the positive control for the same incubation period. The different results related to the cytotoxic potential of DK-164 and CC-78 associated with the examined cellular mechanisms induced in lung cancer cells might be used to conclude the specific functions of the various functional groups in the ferrocene compounds, which can offer new perspectives for the design of antitumour drugs.
Collapse
Affiliation(s)
- Maria Schröder
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Maria Petrova
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Zlatina Vlahova
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Georgi M. Dobrikov
- Institute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 9, 1113 Sofia, Bulgaria; (G.M.D.); (I.S.)
| | - Ivaylo Slavchev
- Institute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 9, 1113 Sofia, Bulgaria; (G.M.D.); (I.S.)
| | - Evdokia Pasheva
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Iva Ugrinova
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
- Correspondence: ; Tel.: +359-887-985-463
| |
Collapse
|
5
|
Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines. Pharmaceuticals (Basel) 2022; 15:ph15030314. [PMID: 35337112 PMCID: PMC8950591 DOI: 10.3390/ph15030314] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Revised: 02/26/2022] [Accepted: 03/02/2022] [Indexed: 12/17/2022] Open
Abstract
Tamoxifen is a long-known anti-tumor drug, which is the gold standard therapy in estrogen receptor (ER) positive breast cancer patients. According to previous studies, the conjugation of the original tamoxifen molecule with different functional groups can significantly improve its antitumor effect. The purpose of this research was to uncover the molecular mechanisms behind the cytotoxicity of different ferrocene-linked tamoxifen derivates. Tamoxifen and its ferrocene-linked derivatives, T5 and T15 were tested in PANC1, MCF7, and MDA-MB-231 cells, where the incorporation of the ferrocene group improved the cytotoxicity on all cell lines. PANC1, MCF7, and MDA-MB-231 express ERα and GPER1 (G-protein coupled ER 1). However, ERβ is only expressed by MCF7 and MDA-MB-231 cells. Tamoxifen is a known agonist of GPER1, a receptor that can promote tumor progression. Analysis of the protein expression profile showed that while being cytotoxic, tamoxifen elevated the levels of different tumor growth-promoting factors (e.g., Bcl-XL, Survivin, EGFR, Cathepsins, chemokines). On the other hand, the ferrocene-linked derivates were able to lower these proteins. Further analysis showed that the ferrocene-linked derivatives significantly elevated the cellular oxidative stress compared to tamoxifen treatment. In conclusion, we were able to find two molecules possessing better cytotoxicity compared to their unmodified parent molecule while also being able to counter the negative effects of the presence of the GPER1 through the ER-independent mechanism of oxidative stress induction.
Collapse
|
6
|
Scattolin T, Moro G, Serena A, Pattaro AG, Rizzolio F, Canzonieri V, Demitri N, Bortolamiol E, Moretto LM, Visentin F. Synthesis, characterization and anticancer activity of Ferrocenyl complexes bearing different organopalladium fragments. Appl Organomet Chem 2022. [DOI: 10.1002/aoc.6629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Thomas Scattolin
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| | - Giulia Moro
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| | - Anita Serena
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| | - Alessia Guadagnin Pattaro
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| | - Flavio Rizzolio
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
- Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, via Franco Gallini 2, 33081 Aviano Italy
| | - Vincenzo Canzonieri
- Pathology Unit, Centro di Riferimento Oncologico di Aviano (C.R.O.) IRCCS, via Franco Gallini 2, 33081 Aviano Italy
- Department of Medical, Surgical and Health Sciences, Università degli Studi di Trieste, Strada di Fiume 447 Trieste Italy
| | - Nicola Demitri
- Area Science Park, Elettra‐Sincrotrone Trieste, S.S. 14 Km 163.5, Basovizza, 34149 Trieste Italy
| | - Enrica Bortolamiol
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| | - Ligia Maria Moretto
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| | - Fabiano Visentin
- Department of Molecular Sciences and Nanosystems Università Ca’ Foscari, Campus Scientifico Via Torino 155, 30174 Venezia‐Mestre Italy
| |
Collapse
|
7
|
Savani CJ, Vennapu DR, Roy H, Singh VK. Effect of chirality and redox potentials on the cytotoxicity of new ferrocene functionalized chiral tertiary amines. J Organomet Chem 2021. [DOI: 10.1016/j.jorganchem.2021.121983] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
8
|
Vessières A, Quissac E, Lemaire N, Alentorn A, Domeracka P, Pigeon P, Sanson M, Idbaih A, Verreault M. Heterogeneity of Response to Iron-Based Metallodrugs in Glioblastoma Is Associated with Differences in Chemical Structures and Driven by FAS Expression Dynamics and Transcriptomic Subtypes. Int J Mol Sci 2021; 22:ijms221910404. [PMID: 34638742 PMCID: PMC8508975 DOI: 10.3390/ijms221910404] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Revised: 09/20/2021] [Accepted: 09/23/2021] [Indexed: 11/18/2022] Open
Abstract
Glioblastoma (GBM) is the most frequent and deadliest primary brain cancer in adults, justifying the search for new treatments. Some members of the iron-based ferrocifen family have demonstrated a high cytotoxic effect on various cancer cell lines via innovative mechanisms of action. Here, we evaluated the antiproliferative activity by wst-1 assay of six ferrocifens in 15 molecularly diverse GBM patient-derived cell lines (PDCLs). In five out of six compounds, the half maximal inhibitory concentration (IC50) values varied significantly (10 nM < IC50 < 29.8 µM) while the remaining one (the tamoxifen-like complex) was highly cytotoxic against all PDCLs (mean IC50 = 1.28 µM). The pattern of response was comparable for the four ferrocifens bearing at least one phenol group and differed widely from those of the tamoxifen-like complex and the complex with no phenol group. An RNA sequencing differential analysis showed that response to the diphenol ferrocifen relied on the activation of the Death Receptor signaling pathway and the modulation of FAS expression. Response to this complex was greater in PDCLs from the Mesenchymal or Proneural transcriptomic subtypes compared to the ones from the Classical subtype. These results provide new information on the mechanisms of action of ferrocifens and highlight a broader diversity of behavior than previously suspected among members of this family. They also support the case for a molecular-based personalized approach to future use of ferrocifens in the treatment of GBM.
Collapse
Affiliation(s)
- Anne Vessières
- Institut Parisien de Chimie Moléculaire, Sorbonne Université, CNRS, UMR CNRS 8232, 4 Place Jussieu, F-75005 Paris, France;
- Correspondence: (A.V.); (M.V.)
| | - Emie Quissac
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, F-75013 Paris, France; (E.Q.); (N.L.); (P.D.)
| | - Nolwenn Lemaire
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, F-75013 Paris, France; (E.Q.); (N.L.); (P.D.)
| | - Agusti Alentorn
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neurosciences, Service de Neurologie 2-Mazarin, F-75013 Paris, France; (A.A.); (M.S.); (A.I.)
| | - Patrycja Domeracka
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, F-75013 Paris, France; (E.Q.); (N.L.); (P.D.)
| | - Pascal Pigeon
- Institut Parisien de Chimie Moléculaire, Sorbonne Université, CNRS, UMR CNRS 8232, 4 Place Jussieu, F-75005 Paris, France;
- Chimie ParisTech-PSL, 11 Rue P. et M. Curie, F-75005 Paris, France
| | - Marc Sanson
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neurosciences, Service de Neurologie 2-Mazarin, F-75013 Paris, France; (A.A.); (M.S.); (A.I.)
| | - Ahmed Idbaih
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, DMU Neurosciences, Service de Neurologie 2-Mazarin, F-75013 Paris, France; (A.A.); (M.S.); (A.I.)
| | - Maïté Verreault
- Institut du Cerveau-Paris Brain Institute-ICM, Inserm, Sorbonne Université, CNRS, APHP, Hôpital de la Pitié Salpêtrière, F-75013 Paris, France; (E.Q.); (N.L.); (P.D.)
- Correspondence: (A.V.); (M.V.)
| |
Collapse
|
9
|
Idlas P, Lepeltier E, Jaouen G, Passirani C. Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors. Cancers (Basel) 2021; 13:2291. [PMID: 34064748 PMCID: PMC8151583 DOI: 10.3390/cancers13102291] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2021] [Revised: 04/29/2021] [Accepted: 05/04/2021] [Indexed: 12/12/2022] Open
Abstract
Resistance of cancer cells to current chemotherapeutic drugs has obliged the scientific community to seek innovative compounds. Ferrocifens, lipophilic organometallic compounds composed of a tamoxifen scaffold covalently bound to a ferrocene moiety, have shown very interesting antiproliferative, cytotoxic and immunologic effects. The formation of ferrocenyl quinone methide plays a crucial role in the multifaceted activity of ferrocifens. Lipid nanocapsules (LNCs), meanwhile, are nanoparticles obtained by a free organic solvent process. LNCs consist of an oily core surrounded by amphiphilic surfactants and are perfectly adapted to encapsulate these hydrophobic compounds. The different in vitro and in vivo experiments performed with this ferrocifen-loaded nanocarrier have revealed promising results in several multidrug-resistant cancer cell lines such as glioblastoma, breast cancer and metastatic melanoma, alone or in combination with other therapies. This review provides an exhaustive summary of the use of ferrocifen-loaded LNCs as a promising nanomedicine, outlining the ferrocifen mechanisms of action on cancer cells, the nanocarrier formulation process and the in vivo results obtained over the last two decades.
Collapse
Affiliation(s)
- Pierre Idlas
- Micro & Nanomedecines Translationnelles (MINT), University of Angers, Inserm, The National Center for Scientific Research (CNRS), SFR ICAT, 49000 Angers, France; (P.I.); (E.L.)
| | - Elise Lepeltier
- Micro & Nanomedecines Translationnelles (MINT), University of Angers, Inserm, The National Center for Scientific Research (CNRS), SFR ICAT, 49000 Angers, France; (P.I.); (E.L.)
| | - Gérard Jaouen
- Sorbonne Universités, Université IPCM, Paris 6, UMR 8232, IPCM, 4 place Jussieu, 75005 Paris, France;
- PSL University, Chimie ParisTech, CNRS, Institut de Recherche de Chimie Paris, 75005 Paris, France
| | - Catherine Passirani
- Micro & Nanomedecines Translationnelles (MINT), University of Angers, Inserm, The National Center for Scientific Research (CNRS), SFR ICAT, 49000 Angers, France; (P.I.); (E.L.)
| |
Collapse
|
10
|
Topin-Ruiz S, Mellinger A, Lepeltier E, Bourreau C, Fouillet J, Riou J, Jaouen G, Martin L, Passirani C, Clere N. p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8 + T lymphocytes. Int J Pharm 2020; 593:120111. [PMID: 33246045 DOI: 10.1016/j.ijpharm.2020.120111] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Revised: 11/12/2020] [Accepted: 11/19/2020] [Indexed: 01/13/2023]
Abstract
Metastatic melanoma is a malignant tumor with a poor prognosis. Recent new therapeutics improved the survival of patients at a metastatic stage. However, the low response rate to immunotherapy, explained in part by resistance to apoptosis, needs to develop new strategies. The ferrocifen family represents promising bioorganometallic molecules for melanoma treatment since they show potent anticancer properties. The aim of this study is (i) to evaluate the benefits of a strategy involving encapsulated p722 in lipid nanocapsules (LNC) in B16F10 melanoma mice models and (ii) to compare the beneficial effects with an existing therapy such as anti-CTLA4 mAb. Interestingly, LNC-p722 induces a significant decrease of melanoma cell viability. In vivo data shows a significant improvement in the survival rate and a slower tumor growth with p722-loaded LNC in comparison with anti-CTLA4 mAb. Western blots confirm that LNC-p722 potentiates intrinsic apoptotic pathway. Treatment with LNC-p722 significantly activates CD8+ T lymphocytes compared to treatment with anti-CTLA4 mAb. This study uncovers a new therapeutic strategy with encapsulated p722 to prevent B16F10 melanoma growth and to improve survival of treated mice.
Collapse
Affiliation(s)
- Solène Topin-Ruiz
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France; Centre Hospitalier Universitaire, service de dermatologie, 4 rue Larrey, F-49933 Angers, France
| | - Adélie Mellinger
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France
| | - Elise Lepeltier
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France
| | - Clara Bourreau
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France
| | - Juliette Fouillet
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France
| | - Jérémie Riou
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France
| | - Gérard Jaouen
- PSL, Chimie ParisTech, Paris Cedex 05, France; Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire (IPCM, UMR 8232), Paris Cedex 05, France
| | - Ludovic Martin
- Centre Hospitalier Universitaire, service de dermatologie, 4 rue Larrey, F-49933 Angers, France
| | - Catherine Passirani
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France
| | - Nicolas Clere
- MINT, Univ Angers, INSERM, CNRS, IBS-CHU, 4 rue Larrey, F-49933 Angers, France.
| |
Collapse
|
11
|
Schwarze B, Jelača S, Welcke L, Maksimović‐Ivanić D, Mijatović S, Hey‐Hawkins E. 2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes. ChemMedChem 2019; 14:2075-2083. [PMID: 31677361 PMCID: PMC6972990 DOI: 10.1002/cmdc.201900554] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2019] [Revised: 10/07/2019] [Indexed: 12/19/2022]
Abstract
Investigations on the antitumor activity of metallacarboranes are sparse in the literature and limited to a handful of ruthena- and molybdacarboranes. In this study, the molybdacarborane fragment [3-(CO)2 -closo-3,1,2-MoC2 B9 H11 ] was combined with a vector molecule, inspired by the well-known drug tamoxifen or 4,4'-dihydroxytamoxifen (TAM-diOH). The molybdacarborane derivative [3,3-{4-[1,1-bis(4-hydroxyphenyl)but-1-en-2-yl]-2,2'-bipyridine-κ2 N,N'}-3-(CO)2 -closo-3,1,2-MoC2 B9 H11 ] (10), as well as the ligand itself 4-[1,1-bis(4-hydroxyphenyl)but-1-en-2-yl]-2,2'-bipyridine (6) showed cytotoxic activities in the low micromolar range against breast adenocarcinoma (MDA-MB-231, MDA-MB-361 and MCF-7), human glioblastoma (LN-229) and human glioma (U-251) cell lines. In addition, compounds 6 and 10 were found to induce senescence and cytodestructive autophagy, lower ROS/RNS levels, but only the molybdacarborane 10 induced a strong increase of nitric oxide (NO) concentration in the MCF-7 cells.
Collapse
Affiliation(s)
- Benedikt Schwarze
- Leipzig UniversityFaculty of Chemistry and Mineralogy, Institute of Inorganic ChemistryJohannisallee 2904103LeipzigGermany
| | - Sanja Jelača
- University of BelgradeDepartment of Immunology, Institute for Biological Research “Siniša Stanković” – National Institute of Republic of SerbiaBul. Despota Stefana 14211060BelgradeSerbia
| | - Linda Welcke
- Leipzig UniversityFaculty of Chemistry and Mineralogy, Institute of Inorganic ChemistryJohannisallee 2904103LeipzigGermany
| | - Danijela Maksimović‐Ivanić
- University of BelgradeDepartment of Immunology, Institute for Biological Research “Siniša Stanković” – National Institute of Republic of SerbiaBul. Despota Stefana 14211060BelgradeSerbia
| | - Sanja Mijatović
- University of BelgradeDepartment of Immunology, Institute for Biological Research “Siniša Stanković” – National Institute of Republic of SerbiaBul. Despota Stefana 14211060BelgradeSerbia
| | - Evamarie Hey‐Hawkins
- Leipzig UniversityFaculty of Chemistry and Mineralogy, Institute of Inorganic ChemistryJohannisallee 2904103LeipzigGermany
| |
Collapse
|
12
|
Babgi BA, Abdellattif MH, Hussien MA, Eltayeb NE. Exploring DNA-Binding and anticancer properties of benzoimidazolyl-ferrocene dye. J Mol Struct 2019. [DOI: 10.1016/j.molstruc.2019.126918] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
13
|
Tonolo F, Salmain M, Scalcon V, Top S, Pigeon P, Folda A, Caron B, McGlinchey MJ, Toillon R, Bindoli A, Jaouen G, Vessières A, Rigobello MP. Small Structural Differences between Two Ferrocenyl Diphenols Determine Large Discrepancies of Reactivity and Biological Effects. ChemMedChem 2019; 14:1717-1726. [DOI: 10.1002/cmdc.201900430] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Revised: 09/04/2019] [Indexed: 02/06/2023]
Affiliation(s)
- Federica Tonolo
- Dipartimento di Scienze BiomedicheUniversità di Padova Via Ugo Bassi 58/b 35131 Padova Italy
| | - Michèle Salmain
- Sorbonne UniversitéCNRS, IPCM 4 Place Jussieu 75005 Paris France
| | - Valeria Scalcon
- Dipartimento di Scienze BiomedicheUniversità di Padova Via Ugo Bassi 58/b 35131 Padova Italy
| | - Siden Top
- Sorbonne UniversitéCNRS, IPCM 4 Place Jussieu 75005 Paris France
| | - Pascal Pigeon
- Sorbonne UniversitéCNRS, IPCM 4 Place Jussieu 75005 Paris France
- Chimie ParisTechPSL University 11 rue Pierre et Marie Curie 75005 Paris France
| | - Alessandra Folda
- Dipartimento di Scienze BiomedicheUniversità di Padova Via Ugo Bassi 58/b 35131 Padova Italy
| | - Benoit Caron
- Sorbonne UniversitéISTeP, ALIPP6 4 Place Jussieu 75005 Paris France
| | | | | | - Alberto Bindoli
- Istituto di Neuroscienze (CNR) Sezione di Padovac/o Dipartimento di Scienze Biomediche Via Ugo Bassi 58/b 35131 Padova Italy
| | - Gérard Jaouen
- Sorbonne UniversitéCNRS, IPCM 4 Place Jussieu 75005 Paris France
- Chimie ParisTechPSL University 11 rue Pierre et Marie Curie 75005 Paris France
| | - Anne Vessières
- Sorbonne UniversitéCNRS, IPCM 4 Place Jussieu 75005 Paris France
| | - Maria Pia Rigobello
- Dipartimento di Scienze BiomedicheUniversità di Padova Via Ugo Bassi 58/b 35131 Padova Italy
| |
Collapse
|
14
|
Nandanwar SK, Kim HJ. Anticancer and Antibacterial Activity of Transition Metal Complexes. ChemistrySelect 2019. [DOI: 10.1002/slct.201803073] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Sondavid K. Nandanwar
- Department of Marine Convergence ProgramPukyong National University Busan 48513 Republic of Korea
| | - Hak Jun Kim
- Department of ChemistryPukyong National University Busan 48513 Republic of Korea
| |
Collapse
|
15
|
Zaki M, Hairat S, Aazam ES. Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies. RSC Adv 2019; 9:3239-3278. [PMID: 35518979 PMCID: PMC9060267 DOI: 10.1039/c8ra07926a] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2018] [Accepted: 12/26/2018] [Indexed: 02/02/2023] Open
Abstract
The advent of the clinically approved drug cisplatin started a new era in the design of metallodrugs for cancer chemotherapy. However, to date, there has not been much success in this field due to the persistence of some side effects and multi-drug resistance of cancer cells. In recent years, there has been increasing interest in the design of metal chemotherapeutics using organometallic complexes due to their good stability and unique properties in comparison to normal coordination complexes. Their intermediate properties between that of traditional inorganic and organic materials provide researchers with a new platform for the development of more promising cancer therapeutics. Classical metal-based drugs exert their therapeutic potential by targeting only DNA, but in the case of organometallic complexes, their molecular target is quite distinct to avoid drug resistance by cancer cells. Some organometallic drugs act by targeting a protein or inhibition of enzymes such as thioredoxin reductase (TrRx), while some target mitochondria and endoplasmic reticulum. In this review, we mainly discuss organometallic complexes of Ru, Ti, Au, Fe and Os and their mechanisms of action and how new approaches improve their therapeutic potential towards various cancer phenotypes. Herein, we discuss the role of structure-reactivity relationships in enhancing the anticancer potential of drugs for the benefit of humans both in vitro and in vivo. Besides, we also include in vivo tumor models that mimic human physiology to accelerate the development of more efficient clinical organometallic chemotherapeutics.
Collapse
Affiliation(s)
- Mehvash Zaki
- Department of Chemistry, King Abdulaziz University Jeddah Saudia Arabia +91 8979086156, +966 561835672
| | - Suboot Hairat
- Department of Biotechnology, Wachemo University Hossana Ethiopia
| | - Elham S Aazam
- Department of Chemistry, King Abdulaziz University Jeddah Saudia Arabia +91 8979086156, +966 561835672
| |
Collapse
|
16
|
Scalcon V, Bindoli A, Rigobello MP. Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors. Free Radic Biol Med 2018; 127:62-79. [PMID: 29596885 DOI: 10.1016/j.freeradbiomed.2018.03.043] [Citation(s) in RCA: 86] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2018] [Revised: 03/21/2018] [Accepted: 03/24/2018] [Indexed: 12/26/2022]
Abstract
Thioredoxin reductase 2 (TrxR2) is a key component of the mitochondrial thioredoxin system able to transfer electrons to peroxiredoxin 3 (Prx3) in a reaction mediated by thioredoxin 2 (Trx2). In this way, both the level of hydrogen peroxide and thiol redox state are modulated. TrxR2 is often overexpressed in cancer cells conferring apoptosis resistance. Due to their exposed flexible arm containing selenocysteine, both cytosolic and mitochondrial TrxRs are inhibited by a large number of molecules. The various classes of inhibitors are listed and the molecules acting specifically on TrxR2 are extensively described. Particular emphasis is given to gold(I/III) complexes with phosphine, carbene or other ligands and to tamoxifen-like metallocifens. Also chemically unrelated organic molecules, including natural compounds and their derivatives, are taken into account. An important feature of many TrxR2 inhibitors is provided by their nature of delocalized lipophilic cations that allows their accumulation in mitochondria exploiting the organelle membrane potential. The consequences of TrxR2 inhibition are presented focusing especially on the impact on mitochondrial pathophysiology. Inhibition of TrxR2, by hindering the activity of Trx2 and Prx3, increases the mitochondrial concentration of reactive oxygen species and shifts the thiol redox state toward a more oxidized condition. This is reflected by alterations of specific targets involved in the release of pro-apoptotic factors such as cyclophilin D which acts as a regulator of the mitochondrial permeability transition pore. Therefore, the selective inhibition of TrxR2 could be utilized to induce cancer cell apoptosis.
Collapse
Affiliation(s)
- Valeria Scalcon
- Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/b, 35131 Padova, Italy.
| | - Alberto Bindoli
- Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/b, 35131 Padova, Italy; Institute of Neuroscience (CNR), Padova Section, c/o Department of Biomedical Sciences, Viale G. Colombo 3, 35131 Padova, Italy
| | - Maria Pia Rigobello
- Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/b, 35131 Padova, Italy.
| |
Collapse
|
17
|
Pejović A, Drabowicz J, Cieslak M, Kazmierczak-Baranska J, Królewska-Golińska K. Synthesis, characterization and anticancer activity of novel ferrocene containing quinolinones: 1-Allyl-2-ferrocenyl-2,3-dihydroquinolin-4(1H)-ones and 1-allyl-2-ferrocenylquinolin-4(1H)-ones. J Organomet Chem 2018. [DOI: 10.1016/j.jorganchem.2018.08.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
18
|
Scalcon V, Salmain M, Folda A, Top S, Pigeon P, Shirley Lee HZ, Jaouen G, Bindoli A, Vessières A, Rigobello MP. Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells. Metallomics 2018. [PMID: 28636040 DOI: 10.1039/c7mt00121e] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Tamoxifen-like metallocifens (TLMs) of the group-8 metals (Fe, Ru, and Os) show strong anti-proliferative activity on cancer cell lines resistant to apoptosis, owing to their unique redox properties. In contrast, the thioredoxin system, which is involved in cellular redox balance, is often overexpressed in cancer cells, especially in tumour types resistant to standard chemotherapies. Therefore, we investigated the effect of these three TLMs on the thioredoxin system and evaluated the input of the metallocene unit in comparison with structurally related organic tamoxifens. In vitro, all three TLMs became strong inhibitors of the cytosolic (TrxR1) and mitochondrial (TrxR2) isoforms of thioredoxin reductase after enzymatic oxidation with HRP/H2O2 while none of the organic analogues was effective. In Jurkat cells, TLMs inhibited mainly TrxR2, resulting in the accumulation of oxidized thioredoxin 2 and cell redox imbalance. Overproduction of ROS resulted in a strong decrease in the mitochondrial membrane potential, translocation of cytochrome c to the cytosol and activation of caspase 3, thus leading to apoptosis. None of these events occurred with organic tamoxifens. The mitochondrial fraction of cells exposed to TLMs contained a high amount of the corresponding metal, as quantified by ICP-OES. The lipophilic and cationic character associated with the singular redox properties of the TLMs could explain why they alter the mitochondrial function. These results provide new insights into the mechanism of action of tamoxifen-like metallocifens, underlying their prodrug behaviour and the pivotal role played by the metallocenic entity in their cytotoxic activity associated with the induction of apoptosis.
Collapse
Affiliation(s)
- Valeria Scalcon
- Dipartimento di Scienze Biomediche, Università di Padova, Via Ugo Bassi 58/b, 35131 Padova, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Liu YT, Sheng J, Yin DW, Xin H, Yang XM, Qiao QY, Yang ZJ. Ferrocenyl chalcone-based Schiff bases and their metal complexes: Highly efficient, solvent-free synthesis, characterization, biological research. J Organomet Chem 2018. [DOI: 10.1016/j.jorganchem.2017.12.022] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Wang Y, Dansette PM, Pigeon P, Top S, McGlinchey MJ, Mansuy D, Jaouen G. A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties. Chem Sci 2018; 9:70-78. [PMID: 29629075 PMCID: PMC5870192 DOI: 10.1039/c7sc04213b] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2017] [Accepted: 11/09/2017] [Indexed: 12/22/2022] Open
Abstract
Organometallic compounds bearing the redox motif [ferrocenyl-ene-phenol] have very promising antiproliferative properties which have been further improved by incorporating pertinent substituents able to engender new mechanisms. Here we show that novel ferrociphenols bearing a hydroxypropyl chain exhibit strong antiproliferative effects, in most cases much better than those of cisplatin, tamoxifen, or of previously described ferrociphenols devoid of this terminal OH. This is illustrated, in the case of one of these compounds, by its IC50 values of 110 nM for MDA-MB-231 triple negative breast cancer cells and of 300 nM for cisplatin-resistant A2780cisR human ovarian cancer cells, and by its GI50 values lower than 100 nM towards a series of melanoma and renal cancer cell lines of the NCI-60 panel. Interestingly, oxidative metabolism of these hydroxypropyl-ferrociphenols yields two kinds of quinone methides (QMs) that readily react with various nucleophiles, such as glutathione, to give 1,6- and 1,8-adducts. Protonation of these quinone methides generates numerous reactive metabolites leading eventually to many rearrangement and cleavage products. This unprecedented and fully characterized metabolic profile involving a wide range of electrophilic metabolites that should react with cell macromolecules may be linked to the remarkable profile of antiproliferative activities of this new series. Indeed, the great diversity of unexpected reactive metabolites found upon oxidation will allow them to adapt to various situations present in the cancer cell. These data initiate a novel strategy for the rational design of anticancer molecules, thus opening the way to new organometallic potent anticancer drug candidates for the treatment of chemoresistant cancers.
Collapse
Affiliation(s)
- Yong Wang
- PSL , Chimie ParisTech , 11 rue Pierre et Marie Curie , F-75005 Paris , France
- Sorbonne Universités , UPMC Univ Paris 6 , UMR 8232 CNRS , IPCM , Place Jussieu , F-75005 Paris , France . ;
| | - Patrick M Dansette
- Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques , UMR 8601 CNRS , Université Paris Descartes , PRES Paris Cité Sorbonne , 45 rue des Saints Pères , 75270 Paris Cedex 06 , France .
| | - Pascal Pigeon
- PSL , Chimie ParisTech , 11 rue Pierre et Marie Curie , F-75005 Paris , France
- Sorbonne Universités , UPMC Univ Paris 6 , UMR 8232 CNRS , IPCM , Place Jussieu , F-75005 Paris , France . ;
| | - Siden Top
- Sorbonne Universités , UPMC Univ Paris 6 , UMR 8232 CNRS , IPCM , Place Jussieu , F-75005 Paris , France . ;
| | - Michael J McGlinchey
- UCD School of Chemistry and Chemical Biology , University College Dublin , Belfield , Dublin 4 , Ireland
| | - Daniel Mansuy
- Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques , UMR 8601 CNRS , Université Paris Descartes , PRES Paris Cité Sorbonne , 45 rue des Saints Pères , 75270 Paris Cedex 06 , France .
| | - Gérard Jaouen
- PSL , Chimie ParisTech , 11 rue Pierre et Marie Curie , F-75005 Paris , France
- Sorbonne Universités , UPMC Univ Paris 6 , UMR 8232 CNRS , IPCM , Place Jussieu , F-75005 Paris , France . ;
| |
Collapse
|
21
|
The inhibition of tyrosinase by some aryl butenes: A desired activity or a side effect to avoid. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2017.07.031] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
|
23
|
Biologically active meta -substituted ferrocenyl nitro and amino complexes: Synthesis, structural elucidation, and DFT calculations. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2017.05.033] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
24
|
Ramadevi P, Singh R, Jana SS, Devkar R, Chakraborty D. Mixed ligand ruthenium arene complexes containing N-ferrocenyl amino acids: Biomolecular interactions and cytotoxicity against MCF7 cell line. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2017.01.020] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
25
|
Wang Y, Pigeon P, McGlinchey MJ, Top S, Jaouen G. Synthesis and antiproliferative evaluation of novel hydroxypropyl-ferrociphenol derivatives, resulting from the modification of hydroxyl groups. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2016.09.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
26
|
Resnier P, Galopin N, Sibiril Y, Clavreul A, Cayon J, Briganti A, Legras P, Vessières A, Montier T, Jaouen G, Benoit JP, Passirani C. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse. Pharmacol Res 2017; 126:54-65. [PMID: 28159700 DOI: 10.1016/j.phrs.2017.01.031] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2017] [Revised: 01/26/2017] [Accepted: 01/27/2017] [Indexed: 12/22/2022]
Abstract
Metastatic melanoma has been described as a highly aggressive cancer with low sensibility to chemotherapeutic agents. New types of drug, such as metal-based drugs (ferrocifens) have emerged and could represent an alternative for melanoma treatment since they show interesting anticancer potential. Furthermore, molecular analysis has evidenced the role of apoptosis in the low sensibility of melanomas and especially of the key regulator, Bcl-2. The objective of this study was to combine two strategies in the same lipid nanocapsules (LNCs): i) gene therapy to modulate anti-apoptotic proteins by the use of Bcl-2 siRNA, and ii) ferrocifens as a new type of anticancer agent. The efficient gene silencing with LNCs was verified by the specific extinction of Bcl-2 in melanoma cells. The cellular toxicity of ferrocifens (ferrociphenol (FcDiOH) or Ansa-FcDiOH) was demonstrated, showing higher efficacy than dacarbazine. Interestingly, the association of siBcl-2 LNCs with Ansa-FcDiOH demonstrated a significant effect on melanoma cell viability. Moreover, the co-encapsulation of siRNA and ferrocifens was successfully performed into LNCs for animal experiments. A reduction of tumor volume and mass was proved after siBcl-2 LNC treatment and Ansa-FcDiOH LNC treatment, individually (around 25%). Finally, the association of both components into the same LNCs increased the reduction of tumor volume to about 50% compared to the control group. In conclusion, LNCs appeared to provide a promising tool for the co-encapsulation of a metal-based drug and siRNA.
Collapse
Affiliation(s)
- Pauline Resnier
- MINT, UNIV Angers, INSERM, CNRS, Université Bretagne Loire, IBS-CHU, 4 rue Larrey, F-49933 Angers, France.
| | - Natacha Galopin
- SCAHU - Faculté de Médecine, Pavillon Ollivier, rue Haute de Reculée, F-49933 Angers, France.
| | - Yann Sibiril
- INSERM U1078 - Equipe 'Transfert de gènes et thérapie génique', Faculté de Médecine, 22 avenue Camille Desmoulins, CS 93837, F-29238 Brest, Cedex 3, France; CHRU de Brest, Service de Génétique Moléculaire et d'histocompatibilité, 5 avenue Maréchal Foch, 29609 Brest, France.
| | - Anne Clavreul
- MINT, UNIV Angers, INSERM, CNRS, Université Bretagne Loire, IBS-CHU, 4 rue Larrey, F-49933 Angers, France.
| | - Jérôme Cayon
- MINT, UNIV Angers, INSERM, CNRS, Université Bretagne Loire, IBS-CHU, 4 rue Larrey, F-49933 Angers, France; PACeM (Plateforme d'Analyse Cellulaire et Moléculaire), SFR ICAT 4208, Université d'Angers, 4 rue Larrey, F-49933 Angers, France.
| | - Alessandro Briganti
- MINT, UNIV Angers, INSERM, CNRS, Université Bretagne Loire, IBS-CHU, 4 rue Larrey, F-49933 Angers, France.
| | - Pierre Legras
- SCAHU - Faculté de Médecine, Pavillon Ollivier, rue Haute de Reculée, F-49933 Angers, France.
| | - Anne Vessières
- CNRS, UMR 8232, ENSCP, 11 rue P. et M. Curie, F-75231 Paris Cedex05, France.
| | - Tristan Montier
- INSERM U1078 - Equipe 'Transfert de gènes et thérapie génique', Faculté de Médecine, 22 avenue Camille Desmoulins, CS 93837, F-29238 Brest, Cedex 3, France; CHRU de Brest, Service de Génétique Moléculaire et d'histocompatibilité, 5 avenue Maréchal Foch, 29609 Brest, France.
| | - Gérard Jaouen
- CNRS, UMR 8232, ENSCP, 11 rue P. et M. Curie, F-75231 Paris Cedex05, France.
| | - Jean-Pierre Benoit
- MINT, UNIV Angers, INSERM, CNRS, Université Bretagne Loire, IBS-CHU, 4 rue Larrey, F-49933 Angers, France.
| | - Catherine Passirani
- MINT, UNIV Angers, INSERM, CNRS, Université Bretagne Loire, IBS-CHU, 4 rue Larrey, F-49933 Angers, France.
| |
Collapse
|
27
|
Sun A, Lin J, Pi C, Xu R, Cui X. Biological Evaluation of Ferrocenyl Olefins: Cancer Cell Growth Inhibition, ROS Production, and Apoptosis Activity. Arch Pharm (Weinheim) 2016; 349:186-92. [PMID: 26841261 DOI: 10.1002/ardp.201500314] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Revised: 01/16/2016] [Accepted: 01/20/2016] [Indexed: 12/23/2022]
Abstract
The antiproliferative effects of various ferrocenyl olefins were evaluated against the cell lines MCF-7 (human breast cancer cells), DLD-1 (human colon adenocarcinoma cells), HUVEC (human umbilical vein endothelial cells), and A549 (human lung carcinoma cells), using the MTT test. IC50 values were determined. Compounds 8, 9, 11, and 12 with high antiproliferative activity were tested for their reactive oxygen species (ROS) production, and cell cycle analysis was performed on A549 cells. The results show that these compounds might perform their antiproliferative activity through inducing ROS generation, apoptosis induction, and cell cycle arrest.
Collapse
Affiliation(s)
- Aijing Sun
- School of Biomedical Sciences, Huaqiao University and Engineering Research Center of Molecular Medicine, Ministry of Education, Quanzhou, P. R. China
| | - Junsheng Lin
- School of Biomedical Sciences, Huaqiao University and Engineering Research Center of Molecular Medicine, Ministry of Education, Quanzhou, P. R. China
| | - Chao Pi
- Department of Chemistry, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou, P. R. China
| | - Ruian Xu
- School of Biomedical Sciences, Huaqiao University and Engineering Research Center of Molecular Medicine, Ministry of Education, Quanzhou, P. R. China
| | - Xiuling Cui
- School of Biomedical Sciences, Huaqiao University and Engineering Research Center of Molecular Medicine, Ministry of Education, Quanzhou, P. R. China.,Department of Chemistry, Henan Key Laboratory of Chemical Biology and Organic Chemistry, Key Laboratory of Applied Chemistry of Henan Universities, Zhengzhou University, Zhengzhou, P. R. China
| |
Collapse
|
28
|
Wani WA, Baig U, Shreaz S, Shiekh RA, Iqbal PF, Jameel E, Ahmad A, Mohd-Setapar SH, Mushtaque M, Ting Hun L. Recent advances in iron complexes as potential anticancer agents. NEW J CHEM 2016. [DOI: 10.1039/c5nj01449b] [Citation(s) in RCA: 99] [Impact Index Per Article: 12.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The iron complexes discussed in this review highlight their promising future as anticancer agents.
Collapse
Affiliation(s)
- Waseem A. Wani
- Institute of Bioproduct Development
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| | - Umair Baig
- Center of Excellence for Scientific Research Collaboration with MIT
- King Fahd University of Petroleum and Minerals
- Dhahran 31261
- Saudi Arabia
| | - Sheikh Shreaz
- Oral Microbiology Laboratory
- Department of Bioclinical Sciences
- Faculty of Dentistry
- Health Sciences Center
- Kuwait University
| | - Rayees Ahmad Shiekh
- Department of Chemistry
- Faculty of Science
- Taibah University
- Al Madinah Al Munawarrah
- Saudi Arabia
| | | | - Ehtesham Jameel
- Department of Chemistry
- B. R. Ambedkar Bihar University
- Muzaffarpur
- India
| | - Akil Ahmad
- Center of Lipids Engineering and Applied Research
- Ibnu Sina Institute for Industrial and Scientific Research
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| | - Siti Hamidah Mohd-Setapar
- Center of Lipids Engineering and Applied Research
- Ibnu Sina Institute for Industrial and Scientific Research
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| | - Md. Mushtaque
- Department of Physical and Molecular Sciences (Chemistry)
- Al-Falah University
- Faridabad
- India
| | - Lee Ting Hun
- Institute of Bioproduct Development
- Universiti Teknologi Malaysia
- 81310 UTM Skudai
- Malaysia
| |
Collapse
|
29
|
Neidlinger A, Kienz T, Heinze K. Spin Trapping of Carbon-Centered Ferrocenyl Radicals with Nitrosobenzene. Organometallics 2015. [DOI: 10.1021/acs.organomet.5b00778] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Andreas Neidlinger
- Institute of Inorganic and
Analytical Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, D-55128 Mainz, Germany
| | - Torben Kienz
- Institute of Inorganic and
Analytical Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, D-55128 Mainz, Germany
| | - Katja Heinze
- Institute of Inorganic and
Analytical Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, D-55128 Mainz, Germany
| |
Collapse
|
30
|
Wang Y, Pigeon P, Top S, McGlinchey MJ, Jaouen G. Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201503048] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
31
|
Wang Y, Pigeon P, Top S, McGlinchey MJ, Jaouen G. Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides. Angew Chem Int Ed Engl 2015; 54:10230-3. [DOI: 10.1002/anie.201503048] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2015] [Indexed: 02/05/2023]
|
32
|
New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur J Med Chem 2015; 97:164-72. [DOI: 10.1016/j.ejmech.2015.04.053] [Citation(s) in RCA: 96] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2014] [Revised: 04/20/2015] [Accepted: 04/25/2015] [Indexed: 01/21/2023]
|
33
|
Ramadevi P, Singh R, Jana SS, Devkar R, Chakraborty D. Ruthenium complexes of ferrocene mannich bases: DNA/BSA interactions and cytotoxicity against A549 cell line. J Photochem Photobiol A Chem 2015. [DOI: 10.1016/j.jphotochem.2015.02.010] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Janka V, Žatko D, Ladislav V, Pál P, Janka P, Gabriela M. Some ferrocenyl chalcones as useful candidates for cancer treatment. In Vitro Cell Dev Biol Anim 2015; 51:964-74. [DOI: 10.1007/s11626-015-9919-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2014] [Accepted: 05/03/2015] [Indexed: 11/28/2022]
|
35
|
Abstract
The mechanisms of action of ferrocifens depend on several features: chemical structures, used concentrations, nature of cancer cells.
Collapse
Affiliation(s)
- Gérard Jaouen
- Sorbonne Universités
- UPMC Univ Paris 06
- IPCM
- F-75005 Paris
- France
| | - Anne Vessières
- Sorbonne Universités
- UPMC Univ Paris 06
- IPCM
- F-75005 Paris
- France
| | - Siden Top
- Sorbonne Universités
- UPMC Univ Paris 06
- IPCM
- F-75005 Paris
- France
| |
Collapse
|
36
|
Ferrocifen derivatives that induce senescence in cancer cells: selected examples. J Inorg Biochem 2014; 141:144-151. [DOI: 10.1016/j.jinorgbio.2014.08.015] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Revised: 08/28/2014] [Accepted: 08/29/2014] [Indexed: 01/01/2023]
|
37
|
Citta A, Folda A, Bindoli A, Pigeon P, Top S, Vessières A, Salmain M, Jaouen G, Rigobello MP. Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells. J Med Chem 2014; 57:8849-59. [DOI: 10.1021/jm5013165] [Citation(s) in RCA: 93] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Anna Citta
- Dipartimento
di Scienze Biomediche, Università di Padova, via Ugo Bassi
58/b, 35131 Padova, Italy
| | - Alessandra Folda
- Dipartimento
di Scienze Biomediche, Università di Padova, via Ugo Bassi
58/b, 35131 Padova, Italy
| | - Alberto Bindoli
- Istituto
di Neuroscienze, CNR, Viale G. Colombo 3, 35121 Padova, Italy
| | - Pascal Pigeon
- Sorbonne Universités, UPMC Univ Paris 06, UMR 8232, IPCM, F-75005 Paris, France
- CNRS, UMR 8232, IPCM, F-75005 Paris, France
- PSL, Chimie ParisTech, 11
rue Pierre et Marie Curie, F-75005 Paris, France
| | - Siden Top
- Sorbonne Universités, UPMC Univ Paris 06, UMR 8232, IPCM, F-75005 Paris, France
- CNRS, UMR 8232, IPCM, F-75005 Paris, France
| | - Anne Vessières
- Sorbonne Universités, UPMC Univ Paris 06, UMR 8232, IPCM, F-75005 Paris, France
- CNRS, UMR 8232, IPCM, F-75005 Paris, France
| | - Michèle Salmain
- Sorbonne Universités, UPMC Univ Paris 06, UMR 8232, IPCM, F-75005 Paris, France
- CNRS, UMR 8232, IPCM, F-75005 Paris, France
| | - Gérard Jaouen
- Sorbonne Universités, UPMC Univ Paris 06, UMR 8232, IPCM, F-75005 Paris, France
- CNRS, UMR 8232, IPCM, F-75005 Paris, France
- PSL, Chimie ParisTech, 11
rue Pierre et Marie Curie, F-75005 Paris, France
| | - Maria Pia Rigobello
- Dipartimento
di Scienze Biomediche, Università di Padova, via Ugo Bassi
58/b, 35131 Padova, Italy
| |
Collapse
|
38
|
Lu C, Heldt JM, Guille-Collignon M, Lemaître F, Jaouen G, Vessières A, Amatore C. Quantitative analyses of ROS and RNS production in breast cancer cell lines incubated with ferrocifens. ChemMedChem 2014; 9:1286-93. [PMID: 24803138 DOI: 10.1002/cmdc.201402016] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2014] [Indexed: 11/10/2022]
Abstract
Ferrocifens are an original class of ferrocifen-type breast cancer drugs. They possess anti-proliferative effects due to the association of the ferrocene moiety and the tamoxifen skeleton. In this work, fluorescence measurements indicated the production of reactive oxygen species (ROS) if hormone-dependent or -independent breast cancer cells were incubated with three hit ferrocifen compounds. Additionally, amperometry at ultramicroelectrodes was carried out to identify and quantify ROS and reactive nitrogen species (RNS) under stress conditions. Videomicroscopy was used to optimize the conditions employed for electrochemical investigations. Amperometry was then performed on two cell lines pre-incubated with each of the three ferrocifens. Interestingly, these results demonstrate that the presence of an aminoalkyl chain in the ferrocifen structure may confer a unique behavior toward both cell lines, in comparison with the two other compounds that lack this feature.
Collapse
Affiliation(s)
- Cong Lu
- Ecole Normale Supérieure-PSL Research University, Département de Chimie, 24 rue Lhomond, 75005 Paris (France), Fax: (+33) 1-4432-3863; Sorbonne Universités, UPMC Univ. Paris 06, PASTEUR, 75005, Paris (France); CNRS, UMR 8640 PASTEUR, 75005, Paris (France)
| | | | | | | | | | | | | |
Collapse
|
39
|
Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Eur J Med Chem 2014; 75:403-12. [DOI: 10.1016/j.ejmech.2014.01.043] [Citation(s) in RCA: 68] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2013] [Revised: 01/17/2014] [Accepted: 01/19/2014] [Indexed: 01/09/2023]
|
40
|
Hegazy WH, Al-Faiyz YS. Synthesis, characterization, and antitumor activities of 1,1′-diacetylferrocene dihydrazone containing phenolic group and its complexes with Pd(II) and Pt(II). Med Chem Res 2013. [DOI: 10.1007/s00044-013-0661-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Vessières A. Metal carbonyl tracers and the ferrocifen family: Two facets of bioorganometallic chemistry. J Organomet Chem 2013. [DOI: 10.1016/j.jorganchem.2012.12.020] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
42
|
Syntheses and in vitro antitumor activities of ferrocene-conjugated Arg-Gly-Asp peptides. J Inorg Biochem 2012; 116:19-25. [DOI: 10.1016/j.jinorgbio.2012.06.014] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2012] [Revised: 06/11/2012] [Accepted: 06/25/2012] [Indexed: 11/24/2022]
|
43
|
Messina P, Hallais G, Labbé E, Béranger M, Chassaing G, Lavielle S, Mansuy C, Buriez O, Amatore C. Electrochemistry of a ferrocene-grafted cell-penetrating peptide. Electrochim Acta 2012. [DOI: 10.1016/j.electacta.2012.06.119] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
44
|
Görmen M, Pigeon P, Hillard EA, Vessières A, Huché M, Richard MA, McGlinchey MJ, Top S, Jaouen G. Synthesis and Antiproliferative Effects of [3]Ferrocenophane Transposition Products and Pinacols Obtained from McMurry Cross-Coupling Reactions. Organometallics 2012. [DOI: 10.1021/om300382h] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Meral Görmen
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Pascal Pigeon
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Elizabeth A. Hillard
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Anne Vessières
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Michel Huché
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Marie-Aude Richard
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Michael J. McGlinchey
- UCD School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland
| | - Siden Top
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| | - Gérard Jaouen
- ENSCP Chimie ParisTech, Laboratoire Charles Friedel
(LCF), 75005 Paris, France
- CNRS, UMR 7223, 75005 Paris, France
| |
Collapse
|
45
|
Messina P, Labbé E, Buriez O, Hillard EA, Vessières A, Hamels D, Top S, Jaouen G, Frapart YM, Mansuy D, Amatore C. Deciphering the activation sequence of ferrociphenol anticancer drug candidates. Chemistry 2012; 18:6581-7. [PMID: 22492462 DOI: 10.1002/chem.201103378] [Citation(s) in RCA: 67] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2011] [Indexed: 11/06/2022]
Abstract
The complete oxidation sequence of a model for ferrociphenols, a new class of anticancer drug candidate, is reported. Cyclic voltammetry was used to monitor the formation of oxidation intermediates on different timescales, thereby allowing the electrochemical characterization of both the short-lived and stable species obtained from the successive electron-transfer and deprotonation steps. The electrochemical preparation of the ferrocenium intermediate enabled a stepwise voltammetric determination of the stable oxidation compounds obtained upon addition of a base as well as the electron stoichiometry observed for the overall oxidation process. A mechanism has been established from the electrochemical data, which involves a base-promoted intramolecular electron transfer between the phenol and the ferrocenium cation. The resulting species is further oxidized then deprotonated to yield a stable quinone methide. To further characterize the transient species successively formed during the two-electron oxidation of the ferrociphenol to its quinone methide, EPR was used to monitor the fate of the paramagnetic species generated upon addition of imidazole to the electrogenerated ferrocenium. The study revealed the passage from an iron-centered to a carbon-centered radical, which is then oxidized to yield the quinone methide, namely, the species that interacts with proteins and so forth under biological conditions.
Collapse
Affiliation(s)
- Pierluca Messina
- UMR CNRS 8640 PASTEUR Ecole Normale Supérieure, Département de Chimie & Université Pierre et Marie Curie, 24 rue Lhomond, 75231 Paris Cedex 05, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Roger M, Clavreul A, Huynh NT, Passirani C, Schiller P, Vessières A, Montero-Menei C, Menei P. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy. Int J Pharm 2012; 423:63-8. [DOI: 10.1016/j.ijpharm.2011.04.058] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2011] [Revised: 04/19/2011] [Accepted: 04/21/2011] [Indexed: 01/01/2023]
|
47
|
de Oliveira AC, Hillard EA, Pigeon P, Rocha DD, Rodrigues FA, Montenegro RC, Costa-Lotufo LV, Goulart MO, Jaouen G. Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: Cancer cell growth inhibition, ROS production and hemolytic activity. Eur J Med Chem 2011; 46:3778-87. [DOI: 10.1016/j.ejmech.2011.05.043] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2011] [Revised: 05/17/2011] [Accepted: 05/18/2011] [Indexed: 11/30/2022]
|
48
|
Quirante J, Dubar F, González A, Lopez C, Cascante M, Cortés R, Forfar I, Pradines B, Biot C. Ferrocene–indole hybrids for cancer and malaria therapy. J Organomet Chem 2011. [DOI: 10.1016/j.jorganchem.2010.11.021] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
Vessières A, Corbet C, Heldt JM, Lories N, Jouy N, Laïos I, Leclercq G, Jaouen G, Toillon RA. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines. J Inorg Biochem 2010; 104:503-11. [DOI: 10.1016/j.jinorgbio.2009.12.020] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2009] [Revised: 12/29/2009] [Accepted: 12/30/2009] [Indexed: 11/16/2022]
|
50
|
Abd-Elzaher MM, Moustafa SA, Labib AA, Ali MM. Synthesis, characterization, and anticancer properties of ferrocenyl complexes containing a salicylaldehyde moiety. MONATSHEFTE FUR CHEMIE 2010. [DOI: 10.1007/s00706-010-0268-6] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|